Given the importance of inflammation in the onset and progression of diabetic cardiomyopathy， we investigated the potential protective effects of triptolide， an anti-inflammatory agent， in streptozotocin-induced diabetic rat model and in H9c2 rat cardiac cells exposed to high glucose.